Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-17

Clinical Trial Update: Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a vitamin/mineral combination as therapy for vertigo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aminobutyric Acid (aminobutyric acid)
  • CYANOCOBALAMIN (cyanocobalamin)
  • Calcium (Calcium)
  • Pyridoxine (Pyridoxine)
  • Thiamine (thiamine)
  • glutamic acid (glutamic acid)

Snippet

Sponsor: Fundação Educacional Serra dos Órgãos | Conditions: Vertigo | Phase 4 | Status: COMPLETED